MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D46FD0.625A1AE0"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA10130101_DE45.files/filelist.xml">
<link rel=3DPreview href=3D"UA10130101_DE45.files/preview.wmf">
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"metricconverter"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Sergii Prymak</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:LastPrinted>2018-08-27T11:20:00Z</o:LastPrinted>
  <o:Created>2018-10-29T19:43:00Z</o:Created>
  <o:LastSaved>2018-10-29T19:43:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1027</o:Words>
  <o:Characters>5857</o:Characters>
  <o:Company>Teva</o:Company>
  <o:Lines>48</o:Lines>
  <o:Paragraphs>13</o:Paragraphs>
  <o:CharactersWithSpaces>6871</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DthemeData href=3D"UA10130101_DE45.files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"UA10130101_DE45.files/colorschememap=
ping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid=3D"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=3Dieooui></objec=
t>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Верхний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 242.2pt right 484.45pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Нижний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 242.2pt right 484.45pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст выноски Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
span.a
	{mso-style-name:"Верхний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Верхний колонтитул";}
span.a0
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Нижний колонтитул";}
span.a1
	{mso-style-name:"Текст выноски Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст выноски";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("UA10130101_DE45.files/header.htm") fs;
	mso-footnote-continuation-separator:url("UA10130101_DE45.files/header.htm"=
) fcs;
	mso-endnote-separator:url("UA10130101_DE45.files/header.htm") es;
	mso-endnote-continuation-separator:url("UA10130101_DE45.files/header.htm")=
 ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 42.5pt 2.0cm 3.0cm;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:520435724;
	mso-list-type:hybrid;
	mso-list-template-ids:2045951738 1201827402 69337091 69337093 69337089 693=
37091 69337093 69337089 69337091 69337093;}
@list l0:level1
	{mso-level-start-at:2;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:21.0pt;
	text-indent:-18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:57.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:93.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:129.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:165.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:201.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:237.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:273.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:309.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
ІНСТРУКЦІЯ<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
для
медичного застосування лікарського засобу<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
ХІЛАК
ФОРТЕ<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
(HYLAK<sup>®</sup>
FORTE)</span></b><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Tim=
es New Roman","serif"'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Склад:<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
діючі
речовини</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman","serif"'>:
100 мл крапель містять водного субстрату метаболітів: <span class=3DSpellE>=
<i>Escherichia</i></span><i>
<span class=3DSpellE>coli</span>, </i>DSM 4087 &#8722; <st1:metricconverter
ProductID=3D"24,9481 г" w:st=3D"on">24,9481 г</st1:metricconverter>, <span
class=3DSpellE><i>Enterococcus</i></span><i> <span class=3DSpellE>faecalis<=
/span>, </i>DSM
4086 &#8722; <st1:metricconverter ProductID=3D"12,4741 г" w:st=3D"on">12,47=
41 г</st1:metricconverter>,
<span class=3DSpellE><i>Lactobacillus</i></span><i> <span class=3DSpellE>ac=
idophilus</span>,
</i>DSM 4149 &#8722; 12,4741 г та водного концентрату метаболітів: <span
class=3DSpellE><i>Lactobacillus</i></span><i> <span class=3DSpellE>helvetic=
us</span>,
</i>DSM 4183 – 49,<st1:metricconverter ProductID=3D"8960 г" w:st=3D"on">896=
0 г</st1:metricconverter>;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>допоміжні
речовини: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif"'>натрію
<span class=3DSpellE>гідрофосфату</span> <span class=3DSpellE>гептагідрат</=
span>,
калію <span class=3DSpellE>гідрофосфат</span>, кислота молочна, кислота фос=
форна
концентрована, калію <span class=3DSpellE>сорбат</span>, кислоти лимонної
моногідрат.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Лактоза входить до складу препарату як продукт
життєдіяльності бактерій.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span style=3D'font-size:12.0pt;font-family:"Times New Roman","seri=
f";
mso-ansi-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Лікарська форма.</span></b><s=
pan
lang=3DUK> </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Ti=
mes New Roman","serif"'>Краплі
оральні, розчин.<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
Основні
фізико-хімічні властивості: </span></i><span lang=3DUK style=3D'font-size:1=
2.0pt;
font-family:"Times New Roman","serif"'>прозорий, жовтувато-коричневого коль=
ору
розчин з характерним кислуватим ароматом карамелі, протягом терміну зберіга=
ння
можуть з’являтися суспендовані частки коричневого кольору.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Фармакотерапевтична</span></b></span><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
font-family:"Times New Roman","serif"'> група. </span></b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-bidi-fo=
nt-weight:
bold'>Засоби, що впливають на травну систему та метаболізм. <span class=3DS=
pellE>Антидіарейні</span>
препарати; засоби, що застосовуються для лікування інфекційно-запальних
захворювань кишечник</span><span style=3D'font-size:12.0pt;font-family:"Tim=
es New Roman","serif";
mso-ansi-language:RU;mso-bidi-font-weight:bold'>а</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-bidi-fo=
nt-weight:
bold'>. <span class=3DSpellE>Антидіарейні</span> мікробні препарати.</span>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
 Код АТХ
А07</span><span lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman","serif";
mso-ansi-language:EN-US'>F</span><span lang=3DEN-US style=3D'font-size:12.0=
pt;
font-family:"Times New Roman","serif"'> </span><span lang=3DEN-US
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
EN-US'>A</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times=
 New Roman","serif"'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Фармакологічні
властивості</span></i></b><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>.<o:p></o:=
p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Краплі <span class=3DSpellE>Хілак</span> форте – лікарський засіб, що
нормалізує кишкову флору, <span class=3DSpellE>рН</span> та водно-електролі=
тний
баланс у просвіті кишечника і стимулює синтез епітеліальних клітин кишкової
стінки.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Природна фізіологічна мікрофлора кишечника може бути значно порушена
внаслідок таких зовнішніх впливів, як терапія антибіотиками, опромінення,
хірургічні втручання на шлунку (операція <span class=3DSpellE>Більрот</span=
> </span><span
lang=3DEN-US style=3D'font-size:12.0pt;font-family:"Times New Roman","serif=
";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-farea=
st-language:
UK'>II</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-fareast-language:UK'>), а так=
ож у
результаті порушення харчування, що іноді може стимулювати<span
style=3D'mso-spacerun:yes'>  </span>надмірне розмноження патогенних мікробі=
в.
Внаслідок цього виникають відчуття тяжкості, метеоризм, пронос або запор. <=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Введені до складу лікарського засобу <span class=3DSpellE>Хілак</span> =
форте
численні продукти обміну фізіологічних кишкових мікробів (виробників молочн=
ої
кислоти, а також <span class=3DSpellE>грампозитивних</span> і <span class=
=3DSpellE>грамнегативних</span>
симбіонтів тонкого та товстого кишечника) сприяють збереженню фізіологічної
функції слизової оболонки кишечника та відновленню його нормальної флори.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Завдяки тому, що <span class=3DSpellE>Хілак</span> форте містить <span
class=3DSpellE>біосинтетичну</span> молочну кислоту та її буферні солі,
нормалізується кислотність у кишечнику.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Летючі кислоти жирного ряду, які містяться у краплях <span class=3DSpel=
lE>Хілак</span>
форте, роблять можливими не тільки профілактику, але і відновлення ушкоджен=
ого
кишкового середовища при інфекційних шлунково-кишкових захворюваннях, вони
також сприяють всмоктуванню води та електролітів (натрій, хлор).<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'>Хілак</span></span><span lang=3DUK style=3D'font-s=
ize:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'> форте не всмоктується в кров, виводиться через
шлунково-кишковий тракт.</span><span lang=3DUK style=3D'font-size:10.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span style=3D'font-size:12.0pt;font-family:"Times New Roman","seri=
f";
mso-ansi-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Клінічні характеристики.<o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Показання.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> Розлади т=
равлення,
такі як метеоризм, діарея, запор;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> під час та
після терапії із застосуванням антибіотиків і сульфаніламідних препаратів, а
також радіотерапії;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> </span><s=
pan
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
RU'>р</span><span class=3DSpellE><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif"'>озлади</span></span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> печінково=
го
метаболізму;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> </span><s=
pan
class=3DSpellE><span style=3D'font-size:12.0pt;font-family:"Times New Roman=
","serif";
mso-ansi-language:RU'>гастроінтестинальні</span></span><span style=3D'font-=
size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:RU'> <span
class=3DSpellE>розлади</span>, <span class=3DSpellE>обумовлені</span></span=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>
зниженою кислотністю;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> </span><s=
pan
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-la=
nguage:
RU'>х</span><span class=3DSpellE><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif"'>ронічний</span></span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> атрофічний
гастроентерит («<span class=3DSpellE>сенільний</span> кишечник»);<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> шлунково-=
кишкові
розлади, пов’язані зі зміною клімату (зокрема, поїздка в теплі країни);<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>–</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> симптоми,
пов’язані з хронічною кишковою інтоксикацією, такі як нудота, порушення
кровообігу, схильність до швидкої втоми тощо.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Застосування цього лікарського засобу є лише
підтримувальним заходом. Його можна застосовувати тільки в комплексі з інши=
ми
ефективними терапевтичними заходами.</span><span lang=3DUK style=3D'font-si=
ze:12.0pt'>
</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Rom=
an","serif"'>Зокрема
при наявності у хворого діареї застосування крапель <span class=3DSpellE>Хі=
лак</span>
форте не заміняє терапію поповнення втрати рідини та інших заходів, таких як
тимчасове утримання від вживання твердої їжі («перерва на чай»).<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Протипоказання.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Підвищена чутливість до складових препарату. Гос=
тра
діарея, що супроводжується високою температурою та наявністю крові у калі.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Взаємодія
з іншими лікарськими засобами та інші види взаємодій.<o:p></o:p></span></i>=
</b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Слід уникати одночасного застосування з антацидн=
ими
засобами.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Препарат має значення <span class=3DSpellE>рН</s=
pan>,
що відповідає кислому середовищу, тому може викликати згортання молока. Чер=
ез
це <span class=3DSpellE>Хілак</span> форте не слід застосовувати з молоком.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Особливості
застосування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'>Хілак</span></span><span lang=3DUK style=3D'font-s=
ize:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'> форте не можна застосовувати без попереднього
розведення (можна розводити водою, чаєм, апельсиновим соком). </span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
1 мл лікарського
засобу <span class=3DSpellE>Хілак</span> форте містить 20&nbsp;крапель.</sp=
an><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-fareast-language:UK'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>Слід порад=
итись
із лікарем при виникненні серйозних симптомів, наприклад гострої діареї з
високою температурою або кров’ю в калі, якщо діарея триває понад 2 дні або
з’являються інші стійкі або нез’ясовані шлунково-кишкові симптоми.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>При виникненні діареї, особливо у дітей та літніх
пацієнтів, обов’язковим при лікуванні є поповнення втрати рідини та
електролітів.</span><span lang=3DUK> </span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Препарат <span class=3DSpellE>Хілак</span> форте=
 слід
з обережністю призначати хворим з підвищеною кислотністю шлункового соку за
наявності <span class=3DSpellE>рефлюкс-езофагіту</span>. Добова доза для та=
ких
хворих не повинна перевищувати 6 мл, яку слід приймати не менш ніж за 3
прийоми.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Хілак</span></span><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> форте міс=
тить
лактозу. Тому препарат не слід призначати пацієнтам при наявності рідкісних
спадкових форм непереносимості галактози, дефіциту лактази або порушення аб=
сорбції
глюкози-галактози.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif"'>Застосування у період вагітно=
сті
або годування груддю.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Немає достатніх епідеміологічних даних щодо вияв=
лення
потенційного ризику застосування препарату під час вагітності або годування=
 груддю.
Перед застосуванням препарату <span class=3DSpellE>Хілак</span> форте у пер=
іод
вагітності або годування груддю слід оцінити співвідношення користь/ризик.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif"'>Здатність впливати на швидкіс=
ть
реакції при керуванні автотранспортом або іншими механізмами.<o:p></o:p></s=
pan></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Препарат
не впливає на швидкість реакції при керуванні автотранспортом або роботі з
іншими механізмами.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span style=3D'font-size:12.0pt;font-family:"Times New Roman","seri=
f";
mso-ansi-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Спосіб
застосування та дози.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'>Хілак</span></span><span lang=3DUK style=3D'font-s=
ize:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'> форте приймають внутрішньо, до або під час їди, р=
озвівши
у невеликій кількості рідини (за винятком молока).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span class=3DSpellE><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'>Хілак</span></span><span lang=3DUK style=3D'font-s=
ize:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:UK'> форте в перші кілька днів хвороби призначають 3 р=
ази
на добу: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-fareast-language:UK'>дорослим і дітям віком від 12 років</span></u><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-fareast-language:UK'> – по 40=
–60
крапель на прийом; <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-fareast-language:UK'>дітям від 2 до 12 років</span></u><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'> – по 20–40 крапель на прийом.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Після покращення стану добову дозу можна зменшити вдвічі.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-layout-grid-align:none'><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'>Хворим із підвищеною кислотністю
шлункового соку та печією, що часто пов’язується з цим станом, добову дозу =
слід
розділити не менш ніж на 3 прийоми.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>Тривалість застосування визначають індивідуально.</span><span lang=3DUK
style=3D'font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif"'>Діти.<o:p></o:p></span></i></=
p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Не застосовують дітям віком до 2 років.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Передозування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Випадків передозування не спостерігалось.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Побічні
реакції.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>За частотою побічні ефекти розподілені таким чин=
ом:
рідко (&#8805; 1/10000, &lt; 1/1000); дуже рідко (&lt; 1/10000).<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
З боку
імунної системи. </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>Рідко: реакція <span class=3DSpellE>гіперчутливо=
сті</span>
у вигляді шкірних реакцій і реакцій слизової оболонки.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
З боку
шлунково-кишкового тракту. </span></i><span lang=3DUK style=3D'font-size:12=
.0pt;
font-family:"Times New Roman","serif"'>Дуже рідко: незначний дискомфорт у
черевній порожнині.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Термін
придатності. </span></i></b><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif"'>5 років.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Після
відкриття флакона </span><span lang=3DUK style=3D'font-size:12.0pt;font-fam=
ily:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
UK'>–</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times Ne=
w Roman","serif"'>
12 місяців.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Умови зберігання.<o:p></o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Зберігати
у недоступному для дітей місці. Лікарський засіб не потребує спеціальних ум=
ов
зберігання.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Упаковка.<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>По
30 або 100 мл розчину у флаконі з пробкою-крапельницею; по 1 флакону у коро=
бці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Категорія відпуску.<o:p></o:p=
></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'>Без
рецепта.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Виробник. <o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span class=3DSpellE><span lang=3DUK style=3D'font-size:12.0pt;font=
-family:
"Times New Roman","serif"'>Меркле</span></span><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif"'> <span class=3DSpellE>ГмбХ</s=
pan>.<b
style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>Місцезнаходження виробника та
адреса місця провадження його діяльності.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span class=3DSpellE><span lang=3DUK style=3D'font-size:12.0pt;font=
-family:
"Times New Roman","serif"'>Людвіг-Меркле-Штрассе</span></span><span lang=3D=
UK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'> 3, 89143 =
<span
class=3DSpellE>Блаубойрен</span>, Німеччина.<o:p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link id=3DMain-File rel=3DMain-File href=3D"../UA10130101_DE45.htm">
<![if IE]>
<base href=3D"file:///C:\68131AB5\UA10130101_DE45.files\header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><o:SmartTagType
 namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"metricconverter"/>
</head>

<body lang=3DRU>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-separ=
ator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-conti=
nuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-separ=
ator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-conti=
nuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

</body>

</html>

------=_NextPart_01D46FD0.625A1AE0
Content-Location: file:///C:/68131AB5/UA10130101_DE45.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA10130101_DE45.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D46FD0.625A1AE0--
